Skip to main content
. 2024 Nov 11;29(1):51. doi: 10.3892/ol.2024.14797

Table I.

Demographic characteristics of the MeS group and the MS group.

Before PSM After PSM


Characteristic Total MeS group (n=1,617) MS group (n=893) P-value MeS group (n=643) MS group (n=643) P-value
Sex 0.017 0.783
  Male 2,060 (82.1) 1,349 (83.4) 711 (79.6) 508 (79.0) 512 (79.6)
  Female 450 (17.9) 268 (16.6) 182 (20.4) 135 (21.0) 131 (20.4)
Age, years 0.916 0.900
  <75 2,365 (94.2) 1,523 (94.2) 842 (94.3) 610 (94.9) 609 (94.7)
  ≥75 145 (5.8) 94 (5.8) 51 (5.7) 33 (5.1) 34 (5.3)
KPS <0.001 0.908
  ≥90 1,419 (56.5) 798 (49.4) 621 (69.5) 410 (63.8) 408 (63.5)
  ≤80 1,091 (43.5) 819 (50.6) 272 (30.5) 233 (36.2) 235 (36.5)
Smoker <0.001 0.954
  No 1,340 (53.4) 724 (44.8) 616 (69.0) 411 (63.9) 412 (64.1)
  Yes 1,170 (46.6) 893 (55.2) 277 (31.0) 232 (36.1) 231 (35.9)
Drinker 0.157 0.852
  No 1,841 (73.3) 1,171 (72.4) 670 (75.0) 467 (72.6) 464 (72.2)
  Yes 669 (26.7) 446 (27.6) 223 (25.0) 176 (27.4) 179 (27.8)
Pathologic differentiation grade 0.204 0.755
  Well G1 455 (18.1) 279 (17.3) 176 (19.7) 120 (18.7) 128 (19.9)
  Moderate G2 1,046 (41.7) 691 (42.7) 355 (39.8) 270 (42.0) 258 (40.1)
  Poor or undifferentiated G3 1,009 (40.2) 647 (40.0) 362 (40.5) 253 (39.3) 257 (40.0)
Lymphovascular invasion 0.147 1.000
  No 442 (17.6) 1,319 (81.6) 749 (83.9) 529 (82.3) 529 (82.3)
  Yes 2,068 (82.4) 298 (18.4) 144 (16.1) 114 (17.7) 114 (17.7)
Nerve invasion 0.133 0.945
  No 487 (19.4) 1289 (79.7) 734 (82.2) 513 (79.8) 514 (79.9)
  Yes 2,023 (80.6) 328 (20.3) 159 (17.8) 130 (20.2) 129 (20.1)
Tumor location <0.001 0.951
  Upper 587 (23.4) 330 (20.4) 257 (28.8) 169 (26.3) 166 (25.8)
  Middle 1,367 (54.5) 893 (55.2) 474 (53.1) 364 (56.6) 363 (56.5)
  Lower 556 (22.2) 394 (24.4) 162 (18.1) 110 (17.1) 114 (17.7)
Pathological T category 0.260 0.987
  T1 202 (8.0) 120 (7.4) 82 (9.2) 62 (9.6) 66 (10.3)
  T2 509 (20.3) 333 (20.6) 176 (19.7) 124 (19.3) 123 (19.1)
  T3 1,584 (63.1) 1,033 (63.9) 551 (61.7) 392 (61.0) 389 (60.5)
  T4 215 (8.6) 131 (8.1) 84 (9.4) 65 (10.1) 65 (10.1)
Pathological N category 0.272 0.903
  N0 1,084 (43.2) 702 (43.4) 382 (42.8) 280 (43.5) 282 (43.9)
  N1 761 (30.3) 505 (31.2) 256 (28.7) 190 (29.5) 197 (30.6)
  N2 450 (17.9) 281 (17.4) 169 (18.9) 111 (17.3) 109 (17.0)
  N3 215 (8.6) 129 (8.0) 86 (9.6) 62 (9.6) 55 (8.6)
8th TNM stage 0.182 0.927
  I 202 (8.0) 120 (7.4) 82 (9.2) 61 (9.5) 62 (9.6)
  II 865 (34.5) 573 (35.4) 292 (32.7) 215 (33.4) 218 (33.9)
  III 1,152 (45.9) 746 (46.1) 406 (45.5) 284 (44.2) 288 (44.8)
  IV 291 (11.6) 178 (11.0) 113 (12.7) 83 (12.9) 75 (11.7)
Thoracic surgery 0.022 0.695
  MIE 1,199 (47.8) 745 (46.1) 454 (50.8) 359 (55.8) 352 (54.7)
  OE 1,311 (52.2) 872 (53.9) 439 (49.2) 284 (44.2) 291 (45.3)
Abdominal surgery <0.001 0.822
  MIE 964 (38.4) 674 (41.7) 290 (32.5) 285 (44.3) 281 (43.7)
  OE 1,542 (61.4) 939 (58.1) 603 (67.5) 358 (55.7) 362 (56.3)
  None 4 (0.2) 0 (0.0)
Surgical approach <0.001 0.631
  McKeown 1,779 (70.9) 1,009 (62.4) 770 (86.2) 528 (82.1) 534 (83.0)
  Iovr-Lewis 691 (27.5) 583 (36.1) 108 (12.1) 109 (17.0) 106 (16.5)
  Sweet 4 (0.2) 4 (0.2) 0 (0.0)
Left thoracotomy and laparotomy 36 (1.4) 21 (1.3) 15 (1.7) 6 (0.9) 3 (0.5)
Clinical treatment modality <0.001 0.939
  Preoperative CT or 46 (1.8) 24 (1.5) 22 (2.5) 16 (2.5) 18 (2.8)
  RT/CRT plus surgery
  Surgery alone 1,269 (50.6) 687 (42.5) 582 (65.2) 395 (61.4) 395 (61.4)
  Surgery plus postoperative 1,195 (47.6) 906 (56.0) 289 (32.4) 232 (36.1) 230 (35.8)
  CT or RT/CRT

Values are expressed as n (%). PSM, performing propensity score matching; MS, manual suturing; MeS, mechanical suturing; KPS, Karnofsky performance status; CRT, chemoradiotherapy; CT, chemotherapy; MIE, minimally invasive esophagectomy; OE, open esophagectomy; RT, radiotherapy.